Shareholders' equity · 2017–2025

Stoke Therapeutics shareholders' equity

$352M+53.9% · FY2025

Stoke Therapeutics (STOK) reported $352M in shareholders' equity for fiscal 2025, +53.9% year on year.

−$1.3M2017$105M2018$224M2019$286M2020$218M2021$185M2022$160M2023$229M2024$352M2025
Stoke Therapeutics — Shareholders' equity, 2017–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31$352M+53.9%Open →
FY20242024-12-31$229M+43.5%Open →
FY20232023-12-31$160M−13.7%Open →
FY20222022-12-31$185M−15.1%Open →
FY20212021-12-31$218M−23.9%Open →
FY20202020-12-31$286M+27.5%Open →
FY20192019-12-31$224M+113.6%Open →
FY20182018-12-31$105M+$106MOpen →
FY20172017-12-31−$1.3M—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Stoke Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/stoke-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Stoke Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/stoke-therapeutics/shareholders-equity

BibTeX

@misc{companiesranked-en-company-stoke-therapeutics-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{Stoke Therapeutics shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/stoke-therapeutics/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-330557 · August 3, 2026

{{cite web |title=Stoke Therapeutics shareholders' equity — 10-Q (0001193125-26-330557) |url=https://www.sec.gov/Archives/edgar/data/1623526/000119312526330557/stok-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Stoke Therapeutics overview